Inventor · disambiguated record
Bruce A. Ellsworth
Also filed as: ELLSWORTH BRUCE · ELLSWORTH BRUCE A
28 granted patents·3 pending applications·1,161 citations·filing 2000–2021
97Inventor score
Files withBRISTOL MYERS SQUIBB CO26SUN CHONGQING2ASTRAZENECA AB1BRISTOL MYERS SQUIBB1ELLSWORTH BRUCE A1
Top patents by PatentIndex Score
31 records- 0198US6515117B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 4, 2003·372 cites·17 claims
- 0298US6414126B1C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 2, 2002·380 cites·30 claims
- 0397US6936590B2C-aryl glucoside SGLT2 inhibitors and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Aug 30, 2005·133 cites·9 claims
- 0495US7375213B2Methods of producing C-aryl glucoside SGLT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 20, 2008·123 cites·21 claims
- 0591US7932379B2Methods of producing C-aryl glucoside SGLT2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 26, 2011·26 cites·13 claims
- 0691US7884113B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Feb 8, 2011·8 cites·8 claims
- 0790US8119808B2Tetrahydroquinoline derivatives as cannabinoid receptor modulatorsSUN CHONGQING·Filed 2011·Granted Feb 21, 2012·8 cites·9 claims
- 0889US7098235B2Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compoundsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 29, 2006·18 cites·11 claims
- 0986US7425550B2Lactam glycogen phosphorylase inhibitors and method of useBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Sep 16, 2008·5 cites·20 claims
- 1086US7057046B2Lactam glycogen phosphorylase inhibitors and method of useBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jun 6, 2006·16 cites·10 claims
- 1184US7629342B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 8, 2009·7 cites·20 claims
- 1284US7378418B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 27, 2008·24 cites·31 claims
- 1382US8288404B2Pyrrolidine GPR40 modulatorsELLSWORTH BRUCE A·Filed 2010·Granted Oct 16, 2012·6 cites·18 claims
- 1479US7223786B22-aminonaphthalene derivatives and related glycogen phosphorylase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·2 cites·7 claims
- 1578US9133163B2Dihydropyrazole GPR40 modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 15, 2015·4 cites·15 claims
- 1678US7037910B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB·Filed 2004·Granted May 2, 2006·10 cites·17 claims
- 1776US7943658B2Indole indane amide compounds useful as CB2 agonists and methodBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 17, 2011·2 cites·14 claims
- 1875US7326706B2Pyrazine modulators of cannabinoid receptorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 5, 2008·6 cites·7 claims
- 1974US9714231B2Pyrrolidine GPR40 modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jul 25, 2017·4 cites·15 claims
- 2072US9604964B2Dihydropyrazole GPR40 modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 28, 2017·2 cites·12 claims
- 2172US7709647B2Tetrahydroquinoline cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted May 4, 2010·1 cites·2 claims
- 2268US9656963B2Dihydropyrazole GPR40 modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·1 cites·15 claims
- 2365US7816357B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 19, 2010·2 cites·24 claims
- 2462US2014243517A1Methods of producing c-aryl glucoside sglt2 inhibitorsASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 2560US7342127B2Substituted anilide ligands for the thyroid receptorBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 11, 2008·1 cites·23 claims
- 2658US12291522B2Galectin-3 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted May 6, 2025·0 cites·16 claims
- 2754US12275719B2Small molecule inhibitors of galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 15, 2025·0 cites·4 claims
- 2854US2011201795A1Methods of Producing C-Aryl Glucoside SGLT2 InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 2953US12269819B2Small molecule inhibitors of Galectin-3BRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 8, 2025·0 cites·13 claims
- 3049US2006160850A1Bicyclic heterocycles as cannabinoid receptor modulatorsSUN CHONGQING·Filed 2006·Application pending·0 cites
- 3140US10301260B2Pyrrolidine GPR40 modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted May 28, 2019·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Bruce A. Ellsworth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →